項目 |
合約覽號(技術覽號 |
項目流水號 |
合約種類 |
合約生效日 |
合約到期日 |
授權技術名稱 |
代表技術創作人 |
1 |
02A-980520 |
3 |
E |
2017/01/01 |
2032/01/06 |
02A-980520 Fabricating scaffolds by microfluidics |
林耿慧、米彥、王禎麒、劉彥良、鍾國元 |
02A-1010123 Fabricating porous martials by the bubble-mixing microfluidic device. |
林耿慧、李怡萱 |
||||||
2 |
05A-1041113 |
2 |
E |
2020/12/28 |
2037/01/19 |
05A-1041113 Building/environment data-based indoor positioning System (BeDIPS) |
張韻詩、蘇展、李正傑(創作人代表為李德財,非創作人) |
3 |
07A-1040804 |
4 |
E |
2019/12/01 |
2039/11/30 |
07A-1040804 Supercontinuum Generating Device and Method |
孔慶昌、鄭佑辰、盧志軒 |
4 |
07A-1060323 |
2 |
E |
2021/01/28 |
2038/08/06 |
07A-1060323 High content cell image-registered photo-induced labeling system |
廖仲麒、陳一德、張至為、鍾穎文 |
07A-1091118 A device to illuminate microscopic patterns in a large area |
廖仲麒、陳一德 |
||||||
07T-1100625 光標靶儀技術介紹動畫 |
廖仲麒、陳一德、張至為 |
||||||
07T-1100626 Software, firmware, IC layout design, and industrial design of the optoproteomics system |
廖仲麒、陳一德、謝永達 |
||||||
5 |
08A-980430 |
1 |
E |
2019/03/21 |
2037/01/06 |
08A-980430 A novel method to constuct two-fluid molten salt reactors |
徐遐生 |
08A-990330 supertorrefaction with liquids as heat transfer agent |
徐遐生、蔡駿、羅芬臺 |
||||||
08A-1030401 Supertorrefaction by Batch Process |
徐遐生、蔡駿、羅芬臺 |
||||||
6 |
10A-1001025 |
1 |
E |
2013/02/01 |
2035/04/30 |
10A-1001025 Anti-EpCAM monoclonal antibodies 3-5-2 |
吳漢忠、廖美英、林政緯 |
7 |
10A-1001025 |
11 |
E |
2020/09/14 |
2042/06/23 |
10A-1001025 Anti-EpCAM monoclonal antibodies 3-5-2 |
吳漢忠、廖美英、林政緯 |
10A-1081029 EpCAM/EpEX signaling promotes PD-L1 stability through EGFR-ERK signaling in lung cancer cells |
|||||||
10A-1091104 Signaling of EpCAM, HFGR and beta-catenin |
|||||||
8 |
10A-1001025B |
2 |
E |
2015/05/01 |
2035/04/30 |
10A-1001025B anti_EpCAM antibody OCAb9-1、EpAb1-3、EpAb5-4 |
吳漢忠 |
9 |
10A-1030805 |
1 |
E |
2018/12/01 |
2034/12/28 |
10A-1030805 Pardaxin treatment of perianal gland adenoma in dog. |
陳志毅、游卓遠、簡基憲 |
10 |
10A-990101 |
3 |
E |
2019/08/01 |
2037/07/31 |
10A-990101 targeting peptide |
吳漢忠、吳建勳 |
11 |
10A-990625 |
1 |
E |
2017/07/14 |
2037/07/14 |
10A-990625 Application of monoclonal antibodies against dengue virus type 2 in diagnosis and therap |
吳漢忠、李璧君、邱倩玉 |
12 |
10T-1070223 |
1 |
E |
2018/10/01 |
2038/10/01 |
10T-1070223 Thrombus-targeted peptides |
吳漢忠 |
13 |
10T-1090709 |
1 |
E |
2021/01/21 |
2041/01/20 |
10T-1090709Development of human antibody mice |
吳漢忠 |
14 |
10T-1090714 |
1 |
E |
2021/01/08 |
2041/01/07 |
10T-1090714 Development of Anti-M13 Antibodies |
吳漢忠 |
15 |
10T-1090715 |
1 |
E |
2021/01/05 |
2041/01/04 |
10T-1090715 Development of anti-HER3 therapeutic antibodies |
吳漢忠 |
16 |
11A-1010209 |
1 |
E |
2018/05/23 |
2033/07/15 |
11A-1010209 Specific A1AT Monoclonal Antibodies For Detection of Endometriosis |
王惠鈞、楊維中、陳水聰、呂肯奮、彭明棋 |
17 |
11A-1030801 |
2 |
E |
2016/09/26 |
2034/09/14 |
11A-1030801 HDAC8 inhibitors for treating cancer |
張崇毅、黃偉展、Ya-Huei Kuo |
18 |
11A-1060407 |
2 |
E |
2020/05/01 |
2037/10/02 |
11A-1060407 Klebsielle pneumoniae capsule polysaccharide conjugated vaccines |
吳世雄、吳宗益、楊鳳玲、王錦堂 |
19 |
11A-941227 |
1 |
E |
2014/05/30 |
2035/05/20 |
11A-941227 Monocotyledon plant indications extract compositions, method of preparation and pharmaceutical compositions containing them |
陳水田 |
11A-1020917 Biological application of Trans-Aconitic Acid (TAA) as a Phosphodiesterase 7 inhibitor |
陳水田、李亦書、陳又群 |
||||||
11A-970326 Cardioprotection by water extracts from monocotyledon plant |
陳水田、 吳世雄、謝榮峯 |
||||||
20 |
11A-971229 |
1 |
E |
2009/05/11 |
2029/04/23 |
11A-971229 Protein Expression System Involving Mutated Severe Respiratory Syndrome-Associated Coronavirus 3C-Like Protease |
梁博煌 |
21 |
12A-1030310 |
2 |
E |
2016/01/01 |
2035/12/31 |
12A-1030310 A reloadable delivery system for systemically administered therapeutics |
謝清河、吳佩蓉、羅傅倫、程華強 |
22 |
12T-1040126 |
1 |
E |
2014/12/07 |
2036/08/31 |
28A-1031012 Small molecules for breast cancer therapy |
翁啟惠 鄭婷仁 鄭偉杰 李文山 王正中 |
12A-1030616 An antagonistic CTLA-4 aptamer and its applications in cancer therapy |
楊泮池 白果能 張翼中 葉劭德 黃舶滄 |
||||||
12A-1030619 An antagonistic PD1 aptamer and its applications in cancer therapy |
楊泮池 張翼中 賴薇云 |
||||||
12A-1021016 Dnazyme for silencing the expression of EGFR |
楊泮池 白果能 賴薇云 張真如 陳琦媛 楊順貞 |
||||||
12A-1040126 An antagonistic PDL1 aptamer and its applications in cancer therapy. |
楊泮池 賴薇云 黃舶滄 |
||||||
28A-1030629 Small molecules for lung cancer therapy |
翁啟惠 楊泮池 鄭婷仁 方俊民 潘思樺 |
||||||
12T-1031121 An all-round platfrom technology for rapid aptamer identification |
楊泮池 |
||||||
23 |
12A-1050113 |
2 |
E |
2016/12/16 |
2036/12/15 |
12A-1050113 Concurrent direct human leukocyte antigen (HLA) genotyping and genome-wide association study (GWAS) reveal major genetic determinants of anti-thyroid druginduced agranulocytosis |
范盛娟、張天鈞、陳沛隆、楊偉勛、施翔蓉 |
24 |
12A-1050421 |
4 |
E |
2020/08/01 |
2037/07/27 |
12A-1050421 Internal fixation of cells and organisms and uses thereof |
胡哲銘、 陳慧文、 陳婉宜、簡禎瑩、林榮辰 |
25 |
12A-920716 |
5 |
E |
2005/11/01 |
2025/10/31 |
12A-920716 Risk assessment for adverse drug reactions |
陳垣崇、洪舜郁、鐘文宏、鄔哲源 |
12A-931129 Genetic variants predicting warfarin sensitivity |
陳垣崇、陳錦澤、阮相宇 |
||||||
26 |
13A-930703 |
4 |
E |
2009/09/15 |
2026/09/07 |
13A-930703 Subcutaneous G-CSF injection in combination with autologous mobilized peripheral blood-hematopoietic stem cell (CD34+) transplantation in chronic stroke animal model |
李鴻、徐偉成、林欣榮 |
27 |
13A-930909 |
2 |
E |
2018/05/15 |
2028/07/31 |
13A-930909 Functional and anatomical recovery in stroke rats receiving intracerebral transplantation of human umbilical cord-derived mesenchymal stem cells |
李鴻、徐偉成、丁大清、林欣榮 |
28 |
14A-1020222 |
1 |
E |
2014/05/10 |
2034/05/09 |
14A-1020222 Use of plant extracts as preventive or therapeutic intervention for fulminant hepatitis, sepsis and sepsis-induced kidney injury, and as de-pigmentation agent |
徐麗芬、馮家華、瑪亞 |
29 |
14A-1030111 |
8 |
E |
2021/09/08 |
2040/11/14 |
14A-1030111 Pdia4 for diabetes diagnosis and treatment |
楊文欽、張力天、黃守賢 |
14A-1080729 Pdia4 inhibitors for beta-cell function and diabetes treatment |
楊文欽、蔡耿彰 |
||||||
30 |
14A-940824 |
2 |
E |
2008/10/01 |
2028/09/30 |
14A-940824 Use of Wedelolactone and IKKα inhibitors to control prostate cancer, benign prostate hypertrophy and androgen-regulated diseases |
蕭培文 |
31 |
14A-941103 |
13 |
E |
2018/11/12 |
2028/11/11 |
14A-941103 Use of 2 β-D-glucopyranosyloxy-1-hydroxytrideca-5,7,9,11-triyne (cytopiloyne) to treat type 2 diabetes |
楊文欽 |
32 |
14A-950305 |
2 |
E |
2014/06/01 |
2114/05/31 |
14A-950305 Use of active galactolipid fraction or derived pure compounds from the Crassocephalum rabens extract as cancer chemopreventive agents |
徐麗芬、侯珈禎、吳志鴻、陳奕平、王升陽、黃啟彰、楊寧蓀 |
33 |
16T-950724 |
2 |
E |
2019/10/08 |
2039/10/07 |
16T-950724 Voices of Orchid Island |
胡台麗 |
34 |
19T-1070521 |
1 |
E |
2018/06/26 |
2028/06/25 |
19T-1070521 The Souls of Black Folk |
何文敬 |
35 |
19T-1090616 |
1 |
E |
2020/12/01 |
2025/11/30 |
19T-1090616 The EU Banking Union: Theories and Policies |
洪德欽 |
36 |
19T-1100726 |
1 |
E |
2022/01/01 |
2026/12/31 |
19T-1100726 Civil Philosophy |
鄧育仁 |
37 |
21T-960330 |
1 |
Eb |
2012/07/10 |
2028/06/27 |
21T-960330 荒木見悟著「佛教與儒教」 |
廖肇亨 |
38 |
21T-970430 |
2 |
E |
2013/09/17 |
2028/09/16 |
21T-970430 Prolegomena to Any Future Metaphysics |
李明輝 |
39 |
26A-1080709 |
1 |
E |
2022/03/09 |
2041/11/13 |
26A-1080709 Helix Air Bladder Based High Efficiency ECP System |
楊富量、鍾昌貴 |
40 |
28A-1000423 |
1 |
E |
2013/04/11 |
2036/01/27 |
28A-1000423 Surface modification to promote binding specific circulating tumor cell detection (Method of Surface Coating to Capture, Purify, and Release Rare Cells |
張瑛芝、吳漢忠、曾柏元 |
28A-1010606 Two-Module Microfluidic System for Rare Cell Capturing and Analysis |
張瑛芝、許佳賢 |
||||||
28A-1030401 Methods and systems for cancer diagnosis and prognosis |
張瑛芝、賴志銘、吳仁家、邵宏仁、陳懷騄 |
||||||
28A-1040320 COLLECTOR ARCHITECTURE LAYOUT DESIGN |
張瑛芝、賴志銘、 |
||||||
41 |
28A-1010820 |
2 |
E |
2014/04/23 |
2033/08/26 |
28A-1010820 寡醣之大規模酵素合成/Large Scale Enzymatic Synthesis of Oligosaccharides |
吳宗益、翁啟惠、 蔡宗義 |
42 |
28A-1030530 |
1 |
E |
2014/11/10 |
2114/11/10 |
28A-1030530 Humanized anti-IgE antibodies that crosslink CD23 on B lymphocytes but do not sensitize cells |
張子文、陳君柏、熊御宇 |
43 |
28A-1031218 |
1 |
E |
2015/06/01 |
2036/01/17 |
28A-1040415 ANTI-HUMAN mIgA ANTIBODIES CAPABLE OF LYSING mIgA-B LYMPHOCYTES AND DECREASING IgA PRODUCTION |
張子文、洪福信、盧建勝 |
28A-1040416 Drug molecules with targeting and effector moieties |
張子文、朱鑫懋 |
||||||
28A-1040417 COMPOSITION AND METHOD FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASES OR AUTOIMMUNE DISEASES |
張子文 |
||||||
28A-1040418 Transgenic animals capable of producing humanized IgE at much higher levels than mouse IgE |
張子文、洪福信、 |
||||||
44 |
28A-1051024 |
6 |
E |
2022/05/25 |
2041/05/06 |
28A-1051024 Nasal spray universal influenza vaccine |
翁啟惠、吳俊毅 |
28A-1090304 A designer chimeric hemagglutinin elicits broad-protective CD4 and CD8 T-cell responses |
翁啟惠、廖心瑜、王世吉、柯怡安、林國儀、馬徹、鄭婷仁 |
||||||
45 |
28A-1061204 |
4 |
E |
2022/01/03 |
2039/11/17 |
28A-1061204 ESI MS for Micro-Sized Bioparticles |
陳仲瑄、歐施莫(Abdil Ozdemir)、林俊利 |
28A-1020910 Automatic Amino Acid Sequencing of Glycopeptide by Y1 Ions |
陳仲瑄、陳建弘、謝欣宇、許邦弘、林俊利 |
||||||
28A-1020201 Portable High Performance Liquid Chromatography |
陳仲瑄、林俊利、謝鎮宇 |
||||||
28A-1020201B HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH UV-VISIBLE DETECTION |
陳仲瑄、謝鎮宇、林俊利 |
||||||
28A-1000927 Periodic Field Differential Mobility Analyzer |
陳仲瑄、Kent Gilling |
||||||
28A-990722B Frequency Scan Linear Ion Trap Mass Spectrometry |
陳仲瑄、盧臆中、朱明禮 |
||||||
28A-980911 Method of single ultra-large molecular ion detection |
陳仲瑄、陳建勳、林俊利、朱明禮 |
||||||
28A-971223 Biomolecule Accelerator |
陳仲瑄、王亦生、林俊利、許勻菲 |
||||||
28A-971223B Molecular Ion Accelerator |
陳仲瑄、王亦生、林俊利、許勻菲 |
||||||
28A-971223C Molecular Ion Accelerator |
陳仲瑄、王亦生、林俊利、許勻菲 |
||||||
46 |
28A-1090204 |
2 |
E |
2021/08/03 |
2041/12/29 |
28T-1090204 Method for organoid generation |
張瑛芝 |
28A-1090203 3D cell culture technology and its applications |
張瑛芝 |
||||||
47 |
28A-1100423 |
7 |
E |
2022/05/25 |
2042/04/11 |
28A-1100423 Monoglycosylated spike vaccine for SARS-CoV-2 and its variants of concern |
馬徹、 翁啟惠、黃菡頤 |
28A-1101026 Broad-spectrum SARS-CoV-2 mRNA vaccine |
翁啟惠、馬徹、吳俊毅、范辰佑 |
||||||
48 |
28A-1100723 |
1 |
E |
2022/05/25 |
2042/12/26 |
28A-1100723 A chimera monoclonal antibody possesses protective activity against various SARA-CoV-2 variants |
林國儀、馬徹、翁啟惠、黃菡頤、王仕文、張毅軒、 陳曉蕊 |
28A-1101116 Monoglycosylated Spike protein-elicited monoclonal antibodies in mice possess protective activity against various SARS-CoV-2 variants |
林國儀、翁啟惠、王仕文、張毅軒 |
||||||
28A-1080311 Synthesis of Sialidase-Resistant Oligosaccharide and Antibody Glycoform Containing α2,6-Linked 3Fax-Neu5Ac |
翁啟惠、駱宏杰 |
||||||
49 |
28A-931014 |
1 |
E |
2005/06/16 |
2025/06/15 |
28T-931014 Methods and compositions associated with administration of an extract of Ganoderma lucidium |
翁啟惠、許先業、花國鋒、林俊宏、許志禛、陳水田、林國儀、楊文彬、游正博、陳鈴津 |
28A-970321 The effect of Reishi-derived polysaccharide and acetic acid on the lifespan of Caenorhabditis elegans |
翁啟惠、邱式鴻、莊明恆、楊文彬 |
||||||
03A-900801 Fucose containing polypeptides and glycopeptides from Ganoderma ludicum |
翁啟惠、林俊成、林俊宏、邱繼輝、陳水田、王元媛、陳鴻森、蔡祐輔 |
||||||
50 |
28A-940701 |
2 |
N |
2009/05/30 |
2029/05/30 |
28A-940701 Fingerprints of polysaccharides by recombinant lectin receptor-Fc Fusion proteins |
謝世良、翁啟惠、陳斯婷、徐翠玲、鄭世進 |
28A-940701B Compositions and methods for identifying response targets and treating flavivrus infection responses |
謝世良、翁啟惠、徐翠玲、陳斯婷 |
||||||
28A-940701D Compositions and methods for identifying response targets and treating flavivrus infection responses |
謝世良、翁啟惠、徐翠玲、陳斯婷、鄭世進 |
||||||
51 |
28A-951222 |
1 |
E |
2009/02/12 |
2029/03/26 |
28A-951222 Use of Alpha-galactosyl ceramide analogs as anti-cancer agents |
翁啟惠、陳鈴津 |
28A-951222B Alpha-galactosyl ceramide analogs and their use as immunotherapies |
翁啟惠、陳鈴津 |
||||||
52 |
28A-960917 |
1 |
E |
2007/09/18 |
2027/09/17 |
28A-960917 Identification of antibacterial and anti-influenza components from fermentation broth samples |
翁啟惠、鄭義循、鄭婷仁 |
53 |
28A-970708 |
1 |
E |
2010/07/26 |
2030/3/9 |
28A-970708 Globo H and related anti-cancer vaccines with novel glycolipid adjuvants |
吳宗益、翁啟惠、陳鈴津、游正博 |
28-970408 Cancer diagnosis based on levels of antibodies against Globo H and its fragments |
吳宗益、翁啟惠、王正琪、陳鈴津 |
||||||
54 |
28A-980327 |
1 |
E |
2009/07/20 |
2043/08/31 |
28A-980327 Development of vaccines in the prevention of viral infection |
翁啟惠、馬徹、王正琪、陳俊叡、曾勇傑 |
28A-980327B Methods For Producing Mono-Glycosylated Influenza Virus Hemagglutinin |
翁啟惠、馬徹、曾勇傑 |
||||||
28A-980327C Methods and Compositions for Immunization Against Virus |
翁啟惠、馬徹、王正琪、陳俊叡 |
||||||
28A-980327D METHODS FOR PRODUCING VIRUS PARTICLES WITH SIMPLIFIED GLYCOSYLATION OF SURFACE PROTEINS |
翁啟惠、馬徹、曾勇傑 |
||||||
55 |
28A-981130 |
2 |
E |
2013/04/12 |
2036/01/24 |
28A-960213 Glycoproteomic probes for fluorescent imaging of fucosylated glycans in vivo |
翁啟惠、徐翠玲,、Sarah R. Hanson、Masaaki Sawa |
28A-960214 Alkynyl sugar analogs for labeling and visualization of glycoconjugates in cells |
翁啟惠、徐翠玲,、Sarah R. Hanson、Masaaki Sawa |
||||||
28A-960215 Tailored Glycoproteomic Methods For The Sequencing, Mapping and Identification of Cellular Glycoproteins |
翁啟惠、徐翠玲,、Sarah R. Hanson |
||||||
28A-970407 Quantitative Microarray of Intact Glycolipid CD1d Interaction and Correlation with Cell-Based Cytokine Production |
翁啟惠、梁碧惠 |
||||||
28A-970410 QUANTITATIVE ANALYSIS OF CARBOHYDRATE-PROTEIN INTERACTIONS USING GLYCAN MICROARRAYS |
翁啟惠、梁碧惠 |
||||||
28A-970411 Glycan arrays on PTFE-like aluminum coated glass slides and related methods |
翁啟惠、吳宗益、 游淑薰 |
||||||
28A-980326 Alpha-Selective Sialyl Phosphate Donors For Preparation Of Sialosides And Sialoside Arrays For Influenza Virus |
翁啟惠、吳宗益、鄭婷仁 |
||||||
28A-981130 Methods for modifying human antibodies by glycan engineering |
翁啟惠、吳宗益 |
||||||
28A-990205 Glycan Arrays For High Throughput Screening Of Viruses |
翁啟惠、吳宗益、梁其輝、楊安綏 |
||||||
28A-990315 Synthesis of Zanamivir Phosphonate Congeners with Anti-influenza Activity |
翁啟惠、方俊民、鄭義循、謝俊結 |
||||||
28A-1010120 Enhanced Anti-Influenza Agents Conjugated With Anti-Inflammatory Activity |
翁啟惠、方俊民、鄭婷仁、詹家琮、鄭義循、柳公政 |
||||||
28A-1010801 Cell-Permeable Probes For Identification And Imaging Of Sialidases |
翁啟惠、方俊民、蔡長昇、鄭義循 |
||||||
28A-1010815 BENZOCYCLOOCTYNE AND THEIR USES |
翁啟惠、方俊民、謝俊結 |
||||||
28A-1020501 GLYCAN CONJUGATES AND USE THEREOF |
翁啟惠、吳宗益、王嘉宏、李秀停 |
||||||
28A-1020503 RM2 ANTIGENS AND USE THEREOF |
翁啟惠、吳宗益、任建台、莊宏揚 |
||||||
28A-1020726 human iNKT cell activation using glycolipids with altered glycosyl groups |
翁啟惠、陳鈴津、吳岱娜、林昆賢 |
||||||
28A-1021222 COMPOSITIONS AND METHODS FOR TREATMENT AND DETECTION OF CANCERS |
翁啟惠、吳宗益,、吳漢忠,、徐翠玲、羅翊偉、 林志偉、葉士齊 |
||||||
28A-1030122 ANTI-CD20 GLYCOANTIBODIES AND USES THEREOF |
翁啟惠、吳宗益、蔡名鴻 |
||||||
28A-1030123 ANTI-CD20 GLYCOANTIBODIES AND USES THEREOF |
翁啟惠、吳宗益 |
||||||
28A-1030124 Anti-TNF-alpha Glycoantibodies and Uses Thereof |
翁啟惠、吳宗益 |
||||||
28A-1030207 FUCOSIDASE FROM BACTEROIDES AND METHODS USING THE SAME |
翁啟惠、蔡宗義 |
||||||
28A-1030321 AZiDO-BODIPY COMPOUNDS AND USES THEREOF |
翁啟惠、方俊民、謝俊結 |
||||||
28A-1030901 HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS |
翁啟惠、陳鈴津、吳岱娜、林昆賢 |
||||||
28A-1031208 NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF |
翁啟惠、吳宗益 |
||||||
28A-1040122 COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY |
翁啟惠、吳宗益、馬徹 |
||||||
28A-1040122B COMPOSITIONS AND METHODS RELATING TO UNIVERSAL GLYCOFORMS FOR ENHANCED ANTIBODY EFFICACY |
翁啟惠、吳宗益、馬徹、吳漢忠 |
||||||
28A-1041211 CANCER MARKERS AND METHODS OF USE THEREOF |
翁啟惠,、吳宗益、徐翠玲、張嘉慈、莊博凱 |
||||||
28A-1050312 Methods for Modular Synthesis of N-glycans and Arrays Thereof |
翁啟惠、吳宗益、施沙晉(Sachin S Shivatare) |
||||||
56 |
28A-990329 |
1 |
E |
2011/04/01 |
2030/02/25 |
28A-990329 Anti-CemX antibodies capable of binding to human mIgE on B lymphocytes |
張子文、陳君柏、吳哲豪、洪福信 |
57 |
28A-990908 |
4 |
E |
2019/06/01 |
2031/10/25 |
28A-990908 Computer-Modeled Novel Cancer Targeting Peptides for Therapy and Imaging |
王勝弘、陳怡如、游正博、陳鈴津、吳漢忠 |
58 |
32T-1010510 |
1 |
E |
2012/01/01 |
2112/01/01 |
32T-1010510 自動化音樂使用情境辨識 |
楊奕軒 |
59 |
32T-1010511 |
1 |
E |
2012/01/01 |
2112/01/01 |
32T-1010511 人類動作影片相似度匹配 |
鄭文皇 |
60 |
10A-1040107 |
1 |
E |
2023/8/15 |
2043/6/7 |
03A-1110221 Potent ionizable cationic lipids, methods for preparation and applications of use thereof |
李文山、吳漢忠、黃智莨、蘇士傑、林秀亭 |
10A-1040107 An Epitope-Substituted Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2 |
吳漢忠、唐中道 |
||||||
10A-1111123 Safety and Immunogenicity of mRNA Vaccine against Dengue Virus Serotype2 |
吳漢忠、蘇士傑、林秀亭 |
||||||
61 |
10A-1090507 |
2 |
E |
2021/5/18 |
2031/5/17 |
10A-1090507 MANUFACTURE METHOD OF FISH RNA INTERFERENCE REAGENT |
吳金洌、 呂明偉、 左淳熙 |
62 |
28A-1101015 |
1 |
E |
2023/9/1 |
2043/4/5 |
28A-1101015 Composition and application of anti-CD33(Siglec-3)mAbs for the treatment of chronic hepatitis B virus infrction |
謝世良、宋佩珊、楊安綏、余忠銘 |
63 |
21T-1031227 |
1 |
E |
2015/1/6 |
2026/1/5 |
21T-1031227 經典譯注計畫研究成果 |
李明輝 |
64 |
25T-1100602 |
1 |
E |
2021/12/16 |
2299/12/31 |
25T-1100602 Property Law: Comparative, Economic, and Empirical Analyses |
張永健 |
65 |
13A-1070619 |
3 |
E |
2022/12/1 |
2032/11/30 |
13A-1070619 Display of spike protein from porcine epidemic diarrhea virus on baculovirus as a vaccine and thereof |
趙裕展、徐偉婷、張惠雯、張佳瑜 |